Jensen, K P
Smith, A H
Herman, A I
Farrer, L A
Kranzler, H R
Sofuoglu, M
Gelernter, J
Article History
Received: 4 May 2015
Revised: 18 February 2016
Accepted: 22 February 2016
First Online: 12 April 2016
Competing interests
: Dr Sofuoglu has served as an expert witness on behalf of Pfizer in lawsuits related to varenicline. Dr Kranzler has served as a consultant or advisory board member for Alkermes, Indivior, Lundbeck and Otsuka. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which is supported by AbbVie, Ethypharm, Lilly, Lundbeck and Pfizer. The remaining authors declare no biomedical financial interests or potential conflicts of interest.